C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/44 (2006.01) C07D 401/14 (2006.01)
Patent
CA 2558893
Compounds of Formula I are antagonists of VLA-4, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of inflammatory bowel disease including ulcerative colitis and Crohn~s disease, multiple sclerosis, asthma, and rheumatoid arthritis.
L'invention concerne des composés représentés par la formule I, qui sont des antagonistes de VLA-4 utiles pour inhiber ou prévenir l'adhérence cellulaire et les pathologies induites par celle-ci. Ces composés sont formulés en compositions pharmaceutiques destinées à traiter des affections intestinales inflammatoires, y compris la rectocolite hémorragique et la maladie de Crohn, la sclérose en plaques, l'asthme et la polyarthrite rhumatoïde.
Hagmann William K.
Lin Linus S.
Liu Ping
Mumford Richard A.
Reger Thomas S.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Vla-4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vla-4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vla-4 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1597121